Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence
AD Raval, KD Kistler, Y Tang, Y Murata… - Transplant Infectious …, 2021 - Wiley Online Library
Kidney transplant recipients (KTRs) have increased risk for cytomegalovirus (CMV)
infection/disease given the necessity of drug‐induced immunosuppression. A …
infection/disease given the necessity of drug‐induced immunosuppression. A …
Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study
C Van Delden, S Stampf, HH Hirsch… - Clinical infectious …, 2020 - academic.oup.com
Background The burden and timeline of posttransplant infections are not comprehensively
documented in the current era of immunosuppression and prophylaxis. Methods In this …
documented in the current era of immunosuppression and prophylaxis. Methods In this …
Sex differences in transplantation
JD Momper, ML Misel, DB McKay - Transplantation Reviews, 2017 - Elsevier
Sex plays a role in the incidence and progression of a wide variety of diseases and
conditions related to transplantation. Additionally, a growing body of clinical and …
conditions related to transplantation. Additionally, a growing body of clinical and …
[HTML][HTML] Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with …
M Fernández-Ruiz, I Rodríguez-Goncer, P Parra… - American Journal of …, 2020 - Elsevier
Monitoring for cytomegalovirus (CMV)-specific cell-mediated immunity (CMV-CMI) may be
useful for individualizing valganciclovir (VGCV) prophylaxis after kidney transplantation (KT) …
useful for individualizing valganciclovir (VGCV) prophylaxis after kidney transplantation (KT) …
Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update
K Prakash, A Chandorkar, KK Saharia - Diagnostics, 2021 - mdpi.com
Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …
CMV-specific cell-mediated immunity at 3-month prophylaxis withdrawal discriminates D+/R+ kidney transplants at risk of late-onset CMV infection regardless the type …
M Jarque, E Melilli, E Crespo, A Manonelles… - …, 2018 - journals.lww.com
Background Whether cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) at
prophylaxis cessation predicts D+/R+ kidney transplants at risk of late-onset CMV infection …
prophylaxis cessation predicts D+/R+ kidney transplants at risk of late-onset CMV infection …
Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice
M Fernández‐Ruiz, M Arias, JM Campistol… - Transplant …, 2015 - Wiley Online Library
There is notable heterogeneity in the implementation of cytomegalovirus (CMV) prevention
practices among CMV‐seropositive (R+) kidney transplant (KT) recipients. In this …
practices among CMV‐seropositive (R+) kidney transplant (KT) recipients. In this …
Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: outcome and risk factors for late CMV disease
JO Reusing Jr, EB Feitosa, F Agena… - Transplant Infectious …, 2018 - Wiley Online Library
Background Anti‐thymocyte globulin (ATG) therapy is a risk factor for cytomegalovirus
(CMV) disease in renal transplant (RT x) recipients and therefore antiviral prophylaxis is …
(CMV) disease in renal transplant (RT x) recipients and therefore antiviral prophylaxis is …
Health information management for research and quality assurance: the Comprehensive Renal Transplant Research Information System
O Famure, NAT Phan, SJ Kim - Healthcare management …, 2014 - journals.sagepub.com
The Kidney Transplant Program at the Toronto General Hospital uses numerous electronic
health record platforms housing patient health information that is often not coded in a …
health record platforms housing patient health information that is often not coded in a …
Relationship between Cytomegalovirus Viremia and Long-Term Outcomes in Kidney Transplant Recipients with Different Donor Ages
D Diena, A Allesina, F Fop, A Mella, R Cavallo, C Costa… - Microorganisms, 2023 - mdpi.com
Objectives: To explore the Cytomegalovirus (CMV) burden on the long-term post-transplant
course in different donor ages, we evaluated the incidence and risk factors for CMV in our …
course in different donor ages, we evaluated the incidence and risk factors for CMV in our …